AzTrials
AzTrials

Comorbidities and Coexisting ConditionsNCT06209944

Charlson Comorbidity Index and Outcome of Cardiopulmonary Resuscitation in Geriatric Patients in Hong Kong

An observational study of Comorbidities and Coexisting Conditions and Cardiopulmonary Resuscitation, run by Jane Yidan Zhu at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to learn about the factors affecting the outcome (survival) of cardiopulmonary resuscitation in older persons in a hospital. The main questions it aims to answer are: Whether age would affect outcome Whether Charlson Comorbidity Index would affect outcome Whether the conditions… Read more about this study

Who is it for?
Ages 65 to 101 years
What is being tested?
Cardiopulmonary resuscitation
Type of treatment
Surgery or procedure
How many people
394 participants
Where
1 siteChina
Study dates
2 May 2019to 31 Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 101 years
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: All adults aged 65 or above with in-hospital cardiac arrest and undergoing CPR in wards of Department of Medicine and Geriatrics (excluding Intensive Care Unit (ICU)) in United Christian Hospital (a regional acute hospital with total bed 1,174 with 16 ICU beds) in Hong Kong from 1 January 2017 to 31 December 2018

Who may be able to join

  • All adults aged 65 or above with in-hospital cardiac arrest and undergoing CPR in wards of Department of Medicine and Geriatrics (excluding Intensive Care Unit (ICU)) in United Christian Hospital (total bed 1,174 with 16 ICU beds) in Hong Kong from 1 January 2017 to 31 December 2018
  • In patients with multiple resuscitation events, only the first in-hospital CPR was included.

Who cannot join

  • Patients with existing Do-Not-Attempt-Cardiopulmonary-Resuscitation (DNACPR) order
  • Patients younger than 65 years old
  • Out-of-hospital CPR in the index admission
  • CPR occurred in ICU / Emergency Department / Operating Theatre / wards other than medical wards

Trial locations and contacts

1 site in 1 country.

China1 site
  • Haven of Hope Hospital

    Hong Kong, Hong Kong

Other trials in China

About this study

Official title: A Retrospective Review on Charlson Comorbidity Index (CCI) as a Predictor of Return-of-spontaneous-circulation and Survival-to-discharge of Geriatric In-hospital Cardiopulmonary Resuscitation (CPR) in a Regional Acute Hospital in Hong Kong

The goal of this observational study is to learn about the factors affecting the outcome (survival) of cardiopulmonary resuscitation in older persons in a hospital. The main questions it aims to answer are:

  • Whether age would affect outcome
  • Whether Charlson Comorbidity Index would affect outcome
  • Whether the conditions (e.g. heart rhythm) immediately before resuscitation would affect survival.

Researchers would compare the patients who deceased with the patients who survived.

Read the detailed description

The goal of this review was to investigate the impact of age, existing medical conditions. and other factors before cardiac arrest in predicting outcome of in-hospital cardiopulmonary resuscitation (CPR) of older persons.

It was conducted on all patients aged ≥ 65, who underwent CPR in acute medical and geriatric wards (excluding Intensive Care Unit) in United Christian Hospital from January 2017 to December 2018.

Being tested
Cardiopulmonary resuscitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cardiopulmonary resuscitationProcedure or surgery

    cardiac compression, endotracheal intubation, defibrillation, and use of cardiovascular medications, to restore circulation in patients with cardiac arrest

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. sustained return of spontaneous circulation (ROSC), survival at 24 hours, survival at hospital discharge, and at 1 year.

    Sustained ROSC is defined as documented return of adequate circulation in the absence of ongoing chest compressions, and the duration should be of 20 minutes or above

    Measured: 2017 - 2018

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2024
  2. Study start2 May 2019
  3. Primary completion31 Dec 2019
  4. Study completion31 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
394 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06209944
Sponsor's protocol ID
CCI and outcome of CPR
Status last verified
Jan 2024
First submitted
1 Oct 2023
Last updated
18 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Comorbidities and Coexisting Conditions and Cardiopulmonary Resuscitation, run by Jane Yidan Zhu at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

sustained return of spontaneous circulation (ROSC), survival at 24 hours, survival at hospital discharge, and at 1 year. (time frame: 2017 - 2018). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in